mRNA vaccine targets pancreatic cancer in breakthrough trial
A cutting-edge mRNA vaccine, similar to COVID-19 jabs, is being developed to combat pancreatic cancer—one of the deadliest forms of the disease. Promising early results offer hope for patients.